BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1969772)

  • 1. Preservation of renal blood flow during hypotension induced with fenoldopam in dogs.
    Aronson S; Goldberg LI; Roth S; Glock D; Moss J; Roizen MF
    Can J Anaesth; 1990 Apr; 37(3):380-4. PubMed ID: 1969772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia.
    Aronson S; Goldberg LI; Glock D; Roth S; Moss J; Roizen MF
    J Cardiothorac Vasc Anesth; 1991 Feb; 5(1):29-32. PubMed ID: 1678284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular function during induced hypotension by fenoldopam or sodium nitroprusside in anesthetized dogs.
    Kien ND; Moore PG; Jaffe RS
    Anesth Analg; 1992 Jan; 74(1):72-8. PubMed ID: 1346487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ; Koster PF; Brooks DP; Ruffolo RR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
    Pollock DM; Arendshorst WJ
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F627-35. PubMed ID: 1969238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI; Smith GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure.
    Poinsot O; Romand JA; Favre H; Suter PM
    Anesthesiology; 1993 Oct; 79(4):680-4. PubMed ID: 8105727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
    Polak MJ; Taylor DA
    Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine DA-1 receptor agonist fenoldopam enhances amino-acid-induced hyperemia in dogs.
    Brooks DP; DePalma D
    Pharmacology; 1993 Jul; 47(1):43-9. PubMed ID: 8101655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine.
    Shi Y; Zalewski A; Bravette B; Maroko AR; Maroko PR
    Am Heart J; 1992 Aug; 124(2):418-23. PubMed ID: 1353297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
    Elliott WJ; Weber RR; Nelson KS; Oliner CM; Fumo MT; Gretler DD; McCray GR; Murphy MB
    Circulation; 1990 Mar; 81(3):970-7. PubMed ID: 1968368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.